Document is current
Any future updates will be listed below
-
Authors
Arai, Hiroyuki https://orcid.org/0000-0002-1886-7070
Xiao, Yi https://orcid.org/0000-0003-3816-461X
Loupakis, Fotios
Kawanishi, Natsuko
Wang, Jingyuan
Battaglin, Francesca
Soni, Shivani
Zhang, Wu
Mancao, Christoph
Salhia, Bodour
Mumenthaler, Shannon M
Weisenberger, Daniel J
Liang, Gangning
Cremolini, Chiara
Falcone, Alfredo
Millstein, Joshua
Lenz, Heinz-Josef
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01374425 at ClinicalTrials.govnct00719797 at ClinicalTrials.govDocuments that mention this clinical trial
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
https://doi.org/10.1136/jitc-2020-001714
Documents that mention this clinical trial
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancer
https://doi.org/10.1136/jitc-2020-001714
-
Funding
Funding for this research was provided by:
Daniel Butler Research Fund
Victoria and Philip Wilson Research Fund
Dhont Family Foundation
National Cancer Institute (P30CA 014089)
San Pedro Peninsula Cancer Guild
Gloria Borges WunderGlo Foundation
- License Information
